Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. The company’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The company’s primary product in clinical development is bremelanotide for the treatment of female sexual dysfunction (FSD). For more information, visit the company’s website at www.palatin.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.